11.18Open11.10Pre Close3 Volume82 Open Interest15.00Strike Price3.35KTurnover1126.84%IV11.16%PremiumJan 17, 2025Expiry Date10.70Intrinsic Value100Multiplier2DDays to Expiry0.48Extrinsic Value100Contract SizeAmericanOptions Type-0.8782Delta0.0590Gamma0.40Leverage Ratio-0.1367Theta-0.0006Rho-0.35Eff Leverage0.0006Vega
Alto Neuroscience Stock Discussion
Alto Neuroscience Announces Data Presented at the 63rd Annual Meeting of the American College of Neuropsychopharmacology
Wednesday, 11th December at 8:03 am
– Data generated from Alto's precision psychiatry platform and clinical-stage product candidates highlighted across three poster presentations and a panel discussion –
– New preclinical data from a reverse translation study demonstrates the link between the mechanism of ALTO-300 and the EEG biomarker used for...
<- Blackrock ->
$Alto Neuroscience (ANRO.US)$
sec.gov/Archive...
#myANROanalysis
Larger Image: tradingview.com...
$Alto Neuroscience (ANRO.US)$
No comment yet